BACKGROUND: Olfactomedin-4 (OLFM4) is a glycoprotein characteristic of intestinal stem cells and apparently involved in mucosal defense of the stomach and colon. Here we studied its expression, regulation and function in IBD. METHODS: The expression of OLFM4, mucins Muc1 and Muc2, the goblet cell differentiation factor Hath1 and the proinflammatory cytokine IL-8 was measured in inflamed or noninflamed colon in IBD patients and controls. OLFM4 protein was located by immunohistochemistry, quantified by Dot Blot and its binding capacity to defensins HBD1-3 was investigated. The influence of bacteria with or without the Notch blocker dibenzazepine (DBZ) and of several cytokines on OLFM4 expression was determined in LS174T cells. RESULTS: OLFM4 mRNA and protein were significantly upregulated in inflamed CD (4.3 and 1.7-fold) and even more pronounced in UC (24.8 and 3.7-fold). OLFM4 expression was correlated to IL-8 but not to Hath1. In controls immunostaining was restricted to the lower crypts but in inflamed IBD it expanded up to the epithelial surface including the mucus. OLFM4 bound to HBD1-3 without profoundly inactivating these defensins. In LS174T-cells OLFM4 mRNA was significantly augmented after incubation with Escherichia coli K12, Escherichia coli Nissle and Bacteroides vulgatus. DBZ downregulated OLFM4 expression and blocked bacterial induction whereas IL-22 but not TNF-α was stimulatory. CONCLUSIONS: OLFM4 is overexpressed in active IBD and secreted into mucus. The induction is triggered by bacteria through the Notch pathway and also by the cytokine IL-22. OLFM4 seems to be of functional relevance in IBD as a mucus component, possibly by binding defensins.
BACKGROUND: Olfactomedin-4 (OLFM4) is a glycoprotein characteristic of intestinal stem cells and apparently involved in mucosal defense of the stomach and colon. Here we studied its expression, regulation and function in IBD. METHODS: The expression of OLFM4, mucins Muc1 and Muc2, the goblet cell differentiation factor Hath1 and the proinflammatory cytokine IL-8 was measured in inflamed or noninflamed colon in IBD patients and controls. OLFM4 protein was located by immunohistochemistry, quantified by Dot Blot and its binding capacity to defensins HBD1-3 was investigated. The influence of bacteria with or without the Notch blocker dibenzazepine (DBZ) and of several cytokines on OLFM4 expression was determined in LS174T cells. RESULTS: OLFM4 mRNA and protein were significantly upregulated in inflamed CD (4.3 and 1.7-fold) and even more pronounced in UC (24.8 and 3.7-fold). OLFM4 expression was correlated to IL-8 but not to Hath1. In controls immunostaining was restricted to the lower crypts but in inflamed IBD it expanded up to the epithelial surface including the mucus. OLFM4 bound to HBD1-3 without profoundly inactivating these defensins. In LS174T-cells OLFM4 mRNA was significantly augmented after incubation with Escherichia coli K12, Escherichia coli Nissle and Bacteroides vulgatus. DBZ downregulated OLFM4 expression and blocked bacterial induction whereas IL-22 but not TNF-α was stimulatory. CONCLUSIONS: OLFM4 is overexpressed in active IBD and secreted into mucus. The induction is triggered by bacteria through the Notch pathway and also by the cytokine IL-22. OLFM4 seems to be of functional relevance in IBD as a mucus component, possibly by binding defensins.
Authors: A D Mandić; E Bennek; J Verdier; K Zhang; S Roubrocks; R J Davis; B Denecke; N Gassler; K Streetz; A Kel; M Hornef; F J Cubero; C Trautwein; G Sellge Journal: Mucosal Immunol Date: 2017-01-18 Impact factor: 7.313
Authors: Kunihiro Kishida; Sarah C Pearce; Shiyan Yu; Nan Gao; Ronaldo P Ferraris Journal: Am J Physiol Gastrointest Liver Physiol Date: 2017-03-23 Impact factor: 4.052
Authors: Rebecca K Donegan; Shannon E Hill; Dana M Freeman; Elaine Nguyen; Susan D Orwig; Katherine C Turnage; Raquel L Lieberman Journal: Hum Mol Genet Date: 2014-12-18 Impact factor: 6.150
Authors: Tianzhen He; Kai Wang; Peng Zhao; Guanqun Zhu; Xinbao Yin; Yulian Zhang; Zongliang Zhang; Kai Zhao; Zhenlin Wang; Ke Wang Journal: FEBS Open Bio Date: 2022-01-12 Impact factor: 2.693
Authors: Rebecca K Donegan; Shannon E Hill; Katherine C Turnage; Susan D Orwig; Raquel L Lieberman Journal: J Biol Chem Date: 2012-11-05 Impact factor: 5.157
Authors: Judith Aron-Wisnewsky; Edi Prifti; Eugeni Belda; Farid Ichou; Brandon D Kayser; Maria Carlota Dao; Eric O Verger; Lyamine Hedjazi; Jean-Luc Bouillot; Jean-Marc Chevallier; Nicolas Pons; Emmanuelle Le Chatelier; Florence Levenez; Stanislav Dusko Ehrlich; Joel Dore; Jean-Daniel Zucker; Karine Clément Journal: Gut Date: 2018-06-13 Impact factor: 23.059